Rosuvastatin in Older Patients with Systolic Heart Failure
John Kjekshus(Nuffield Health), John Wikstrand(Nuffield Health), Michael Böhm(Saarland University), J Korewicki(Apple (Israel)), Cândida Fonseca, John G.F. Cleland(University of Glasgow), Jan H. Cornel(Brigham and Women's Hospital), Lars Gullestad(Oslo University Hospital), John J.V. McMurray(University of Glasgow), Eduard Apetrei(Apple (Israel)), Finn Waagstein(Apple (Israel)), Assen Goudev(Apple (Israel)), J Hradec(Apple (Israel)), Maria Schaufelberger(Apple (Israel)), Dirk J. van Veldhuisen(University Medical Center Groningen), Johan Vanhaecke(Apple (Israel)), François Mach(University of Geneva), Naresh Ranjith(Apple (Israel)), Gabriel Kamenský(Apple (Israel)), Michel Komajda(Apple (Israel)), Peter Dunselman(Apple (Israel)), Peer Grande(Apple (Israel)), András Jánosi(Apple (Israel)), Åke Hjalmarson(Apple (Israel)), Vivencio Barrios(Apple (Israel)), Timo Kuusi(Apple (Israel)), Hans Wedel(Sahlgrenska University Hospital)
Cited by 1,491
Related Papers
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2021|13.1k
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
|New England Journal of Medicine|2017|9.1k
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
|European Heart Journal|2012|6.9k
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
|New England Journal of Medicine|2019|6.8k